Amylx Pharmaceuticals Inc vs Capri Holdings Ltd — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Capri Holdings Ltd trades at $15.62 (market cap $1.75B). The key difference: Amylx Pharmaceuticals Inc is the larger of the two by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Capri Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| AMLX | CPRI | |
|---|---|---|
Market Cap | $2.64B | $1.75B |
Sector | Health | Consumer Staples |
52-Week High | $24.19 | $27.66 |
52-Week Low | $7.82 | $14.98 |
Enterprise Value | $2.39B | $3.03B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →